Exudative Inflammatory Lesions in the Nasal Cavities of the 26-Week Tg.rasH2 Mice Oral Gavage Carcinogenicity Studies

被引:1
|
作者
Paranjpe, Madhav G. [1 ]
Belich, Jessica L. [1 ]
Richardson, Dayauna R. [1 ]
Vidmar, Tom [2 ]
Mann, Peter C. [3 ]
McKeon, Marie E. [1 ]
Elbekai, Reem H. [4 ]
Brown, Caren [1 ]
机构
[1] BioReliance SAFC, 14920 Broschart Rd, Rockville, MD 20850 USA
[2] BioSTAT Consultants Inc, Portage, MI USA
[3] Expt Pathol Labs, Seattle, WA USA
[4] PAREXEL Int, Bethesda, MD USA
关键词
Tg.rasH2; nasal cavity; exudative inflammation; historical incidence; nasal cavity tumors; carcinogenicity studies; RATS; REFLUX;
D O I
10.1177/1091581816673583
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Three levels of nasal cavity sections (anterior, middle, and most posterior) are routinely examined as protocol required tissues in our 26-week carcinogenicity studies involving Tg.rasH2 mice. Exudative inflammation of the nasal cavity was noted in the most posterior section of both males and females that were administered vehicle and/or test article via oral gavage, particularly when the vehicle and/or test article had irritant properties, was in the form of a salt, had a low pH, and/or was viscous. The exudative inflammatory lesion was characterized by the presence of eosinophilic proteinaceous fluid, fibrin, mucin, sloughed cells, and degenerate neutrophils within the nasal cavities. In lesions of increased severity, there was often degeneration, necrosis, and erosion of the underlying mucosa. Often, there was hyperplasia as well as squamous metaplasia of the mucosa. Retrospective analysis of our data, involving thirty-two 26-week Tg.rasH2 carcinogenicity studies, revealed that despite the presence of these exudative inflammatory changes with degeneration, necrosis, and mucosal hyperplasia, progression to tumor formation in the nasal cavities was rare and the incidence of nasal tumors was comparable in animals with or without exudative inflammatory lesions.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 44 条
  • [31] 26-Week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-rasH2 transgenic mice
    Cho, Wan-Seob
    Jeong, Jayoung
    Choi, Mina
    Park, Sue Nie
    Han, Beom Seok
    Son, Woo-Chan
    [J]. ARCHIVES OF TOXICOLOGY, 2011, 85 (01) : 59 - 66
  • [32] 26-Week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-rasH2 transgenic mice
    Wan-Seob Cho
    Jayoung Jeong
    Mina Choi
    Sue Nie Park
    Beom Seok Han
    Woo-Chan Son
    [J]. Archives of Toxicology, 2011, 85 : 59 - 66
  • [33] Assessment of Pig-a, Micronucleus, and Comet Assay Endpoints in Tg.RasH2 Mice Carcinogenicity Study of Aristolochic Acid I
    Chen, Ruixue
    Zhou, Changhui
    Cao, Yiyi
    Xi, Jing
    Ohira, Toko
    He, Liang
    Huang, Pengcheng
    You, Xinyue
    Liu, Weiying
    Zhang, Xinyu
    Ma, Shuangcheng
    Xie, Tianpei
    Chang, Yan
    Luan, Yang
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2020, 61 (02) : 266 - 275
  • [34] A 26-Week Carcinogenicity Study with the Novel Glucagon Analog Dasiglucagon in CByB6F1-Tg(HRAS)2Jic Mice
    Elander, Mikael
    Froud, Adam
    [J]. DIABETES, 2021, 70
  • [35] Preclinical safety of ginsenoside compound K: Acute, and 26-week oral toxicity studies in mice and rats
    Gao, Yonglin
    Wang, Tong
    Wang, Guangfei
    Li, Guisheng
    Sun, Chengfeng
    Jiang, Zhumao
    Yang, Jianrong
    Li, Yanshen
    You, Yanli
    Wu, Xuran
    Sun, Liqin
    Wang, Hongbo
    Li, Chunmei
    Tian, Jingwei
    Zhu, Jing
    Wang, Kezhou
    Cho, Susan
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2019, 131
  • [36] Historical control data of neoplatic lesions in transgenic CBYB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice
    Paranjpe, Madhav
    Elbekai, Reem
    [J]. TOXICOLOGY LETTERS, 2013, 221 : S207 - S207
  • [37] Lung Tumor Induction by 26-week Dermal Application of 1,2-Dichloroethane in CB6F1-Tg rasH2 Mice
    Suguro, Mayuko
    Numano, Takamasa
    Kawabe, Mayumi
    Doi, Yuko
    Imai, Norio
    Mera, Yukinori
    Tamano, Seiko
    [J]. TOXICOLOGIC PATHOLOGY, 2017, 45 (03) : 427 - 434
  • [38] Historical control database of non-neoplastic lesions in transgenic CBYB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice
    Elbekai, Reem
    Paranjpe, Madhav
    [J]. TOXICOLOGY LETTERS, 2013, 221 : S207 - S207
  • [39] Evaluation of the Carcinogenic Potential of Enarodustat (JTZ-951), a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor, in 26-Week Tg.rasH2 Mouse Study and 2-Year Sprague-Dawley Rat Study
    Kemmochi, Yusuke
    Toyoda, Kaoru
    Ishida, Tomio
    Yasui, Yuzo
    Shoda, Toshiyuki
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2023, 42 (06) : 489 - 503
  • [40] Evaluation of Background Data from rasH2 Mice Used in 26 Week Carcinogenicty Studies
    Mansell, P.
    Bonnette, K.
    Adamou, A.
    Jolette, J.
    Kangas, L.
    Morse, M.
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2014, 33 (01) : 62 - 62